Security key
60770K107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 276,578,373
- Total 13F value
- $11,499,056,660
- Share change
- +12,050,450
- Put/Call ratio
- 127%
- SEC-reported price per share
- $41.58
- Number of holders
- 729
- Value change
- +$341,051,932
- Number of buys
- 299
- Number of sells
- 413
- Shares outstanding
- 395,799,522
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
729
Top holders
10
MRNA full security history
Ownership snapshot
Full 13F holder table
Moderna, Inc. SEC filings
Moderna, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 5
BAILLIE GIFFORD & CO
11%
VANGUARD GROUP INC
10%
BlackRock, Inc.
6.3%
FMR LLC
4.4%
STATE STREET CORP
4.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
Company
|
11%
|
$2,837,473,687
42,458,083 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
10%
|
$2,688,317,881
40,226,214 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
6.3%
|
$1,672,889,419
25,032,013 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
4.4%
|
$1,161,650,081
17,382,165 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
4.3%
|
$1,125,899,178
16,847,212 shares
|
— | 30 Sep 2024 |
| Theleme Partners LLP |
13F
Company
|
1.8%
|
$482,971,120
7,226,861 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
729
Shares
276,578,373
Rows available
729
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
765
Q4 2024 holders
729
Holder diff
-36
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|